422 related articles for article (PubMed ID: 22865837)
1. A stability-indicating HPLC method for the determination of bazedoxifene acetate and its related substances in active pharmaceutical ingredient.
Visweswara Rao K; Reddy KP; Kumari KS; Srinivas M
J Chromatogr Sci; 2013 Mar; 51(3):215-21. PubMed ID: 22865837
[TBL] [Abstract][Full Text] [Related]
2. Stability indicating LC method for rapid determination of related substances of O-desmethyl venlafaxine in active pharmaceutical ingredients and pharmaceutical formulations.
Rao KV; Reddy KP; Kumar YR
J Chromatogr Sci; 2014; 52(10):1247-54. PubMed ID: 24474426
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
[TBL] [Abstract][Full Text] [Related]
4. A novel and rapid validated stability-indicating UPLC method of related substances for dorzolamide hydrochloride and timolol maleate in ophthalmic dosage form.
Sharma N; Rao SS; Reddy AM
J Chromatogr Sci; 2012 Oct; 50(9):745-55. PubMed ID: 22562819
[TBL] [Abstract][Full Text] [Related]
5. Stability-indicating UPLC method for determination of Valsartan and their degradation products in active pharmaceutical ingredient and pharmaceutical dosage forms.
Krishnaiah Ch; Reddy AR; Kumar R; Mukkanti K
J Pharm Biomed Anal; 2010 Nov; 53(3):483-9. PubMed ID: 20646890
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a stability-indicating RP-HPLC method for the simultaneous estimation of process related impurities and degradation products of rasagiline mesylate in pharmaceutical formulation.
Reddy PS; Sudhakar Babu K; Kumar N
J Chromatogr Sci; 2013 Mar; 51(3):242-9. PubMed ID: 22988002
[TBL] [Abstract][Full Text] [Related]
7. Development of stability-indicating UHPLC method for the quantitative determination of silodosin and its related substances.
Shaik JV; Saladi S; Sait SS
J Chromatogr Sci; 2014 Aug; 52(7):646-53. PubMed ID: 23845884
[TBL] [Abstract][Full Text] [Related]
8. Quality by design approach for the separation of naproxcinod and its related substances by fused core particle technology column.
Inugala UR; Pothuraju NR; Vangala RR
J Chromatogr Sci; 2013; 51(5):453-9. PubMed ID: 23060406
[TBL] [Abstract][Full Text] [Related]
9. UPLC and LC-MS studies on degradation behavior of irinotecan hydrochloride and development of a validated stability-indicating ultra-performance liquid chromatographic method for determination of irinotecan hydrochloride and its impurities in pharmaceutical dosage forms.
Kumar N; Sangeetha D; Reddy SP
J Chromatogr Sci; 2012 Oct; 50(9):810-9. PubMed ID: 22661461
[TBL] [Abstract][Full Text] [Related]
10. A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant.
Lalitha Devi M; Chandrasekhar KB
J Pharm Biomed Anal; 2009 Dec; 50(5):710-7. PubMed ID: 19632800
[TBL] [Abstract][Full Text] [Related]
11. A validated stability indicating ultra performance liquid chromatographic method for determination of impurities in Esomeprazole magnesium gastro resistant tablets.
Nalwade SU; Reddy VR; Rao DD; Morisetti NK
J Pharm Biomed Anal; 2012 Jan; 57():109-14. PubMed ID: 21920688
[TBL] [Abstract][Full Text] [Related]
12. A validated stability-indicating normal phase LC method for clopidogrel bisulfate and its impurities in bulk drug and pharmaceutical dosage form.
Durga Rao D; Kalyanaraman L; Sait SS; Venkata Rao P
J Pharm Biomed Anal; 2010 May; 52(1):160-5. PubMed ID: 20074888
[TBL] [Abstract][Full Text] [Related]
13. Stability-indicating UPLC method for determining related substances and degradants in dronedarone.
Pydimarry SP; Cholleti VK; Vangala RR
J Chromatogr Sci; 2014 Aug; 52(7):666-75. PubMed ID: 23863770
[TBL] [Abstract][Full Text] [Related]
14. A validated stability-indicating UPLC method for desloratadine and its impurities in pharmaceutical dosage forms.
Rao DD; Satyanarayana NV; Malleswara Reddy A; Sait SS; Chakole D; Mukkanti K
J Pharm Biomed Anal; 2010 Feb; 51(3):736-42. PubMed ID: 19815361
[TBL] [Abstract][Full Text] [Related]
15. A validated stability-indicating LC method for acetazolamide in the presence of degradation products and its process-related impurities.
Srinivasu P; Subbarao DV; Vegesna RV; Sudhakar Babu K
J Pharm Biomed Anal; 2010 May; 52(1):142-8. PubMed ID: 20053517
[TBL] [Abstract][Full Text] [Related]
16. Stability-indicating UPLC method for determination of Imatinib Mesylate and their degradation products in active pharmaceutical ingredient and pharmaceutical dosage forms.
Nageswari A; Reddy KV; Mukkanti K
J Pharm Biomed Anal; 2012 Jul; 66():109-15. PubMed ID: 22502910
[TBL] [Abstract][Full Text] [Related]
17. Quantification of potential impurities by a stability indicating UV-HPLC method in niacinamide active pharmaceutical ingredient.
Thomas S; Bharti A; Tharpa K; Agarwal A
J Pharm Biomed Anal; 2012 Feb; 60():86-90. PubMed ID: 22115882
[TBL] [Abstract][Full Text] [Related]
18. A validated stability-indicating UPLC method for the determination of impurities in Maraviroc.
Chilukuri M; Hussainreddy K; Narayanareddy P; Venkataramana M
J Chromatogr Sci; 2014 Aug; 52(7):609-16. PubMed ID: 23825352
[TBL] [Abstract][Full Text] [Related]
19. A stability indicating simultaneous dual wavelength UV-HPLC method for the determination of potential impurities in fampridine active pharmaceutical ingredient.
Thomas S; Shandilya S; Bharti A; Agarwal A
J Pharm Biomed Anal; 2012 Jan; 58():136-40. PubMed ID: 22000073
[TBL] [Abstract][Full Text] [Related]
20. Stability-indicating HPLC method for the determination of darunavir ethanolate.
Reddy BV; Jyothi G; Reddy BS; Raman NV; Reddy KS; Rambabu C
J Chromatogr Sci; 2013; 51(5):471-6. PubMed ID: 23097581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
